Open partnerships within the oncology community enable us to realize the power of collaboration, leading to the development of breakthrough therapies. Working with patient groups and advocates helps us better understand patient needs and barriers to treatment success.
At the core, Novartis Oncology believes in the human dimension of patients and engages with patient groups and advocates to elevate their voice—in our company and to the world. We start by listening to patient groups and advocates in line with our areas of focus to understand the experience of people living with cancer and related diseases. As a result of this understanding, we endeavor to enhance the capabilities of patient groups to serve the people they represent and develop shared solutions to achieve common goals. Further, we believe patient groups are crucial to addressing emerging patient needs in an era of personalized medicine and cancer as a chronic disease, and we encourage their adaptation to these new realities.
At Novartis Oncology, we realize the power of collaboration in our work with patients, caregivers, patient groups and advocates every day:
We dedicate local resources throughout the world to connect with more than 550 patient groups.
We support networks of patient groups and advocates to share information and best practices.
We facilitate connections among multiple stakeholders to address patient and caregiver needs.
We share our knowledge and lead an exchange of ideas within the patient advocacy movement about how cancer is changing and impacting patient needs.